Alice Ho, MD MBA

19 posts

Alice Ho, MD MBA

Alice Ho, MD MBA

@AliceHoMD

Radiation Oncologist.#BreastCancer Clinical #Research.Focus on #TNBC, #immunotherapy, postmastectomy RT, complications & reconstruction.#stopasianhate.

Raleigh, NC Katılım Kasım 2016
88 Takip Edilen251 Takipçiler
Naim Rashid
Naim Rashid@naimurashid·
Excited to share the news of my appointment to associate prof with tenure @uncbiostat! Milestones like this don’t happen alone, and are made possible by amazing mentors, colleagues, collaborators, students, and especially family Thank you for everything, and for believing in me
Naim Rashid tweet media
Chapel Hill, NC 🇺🇸 English
24
6
136
14.8K
Corey Speers
Corey Speers@cwspeers·
For those who think we’re only interested in removing radiation☢️ 😉…. Excited to work with the team on these three projects and help lead Project 3 #GoBlue @UMichRadOnc @DrSpratticus @caseccc
U-M Rogel Cancer Center@UMRogelCancer

A team of #RogelCancer researchers has received a grant from @theNCI to further radiosensitization research. The grant, worth $11.1M, is funded through @theNCI's SPORE, or Specialized Program of Research Excellence. Congrats all! @UMichRadOnc michmed.org/3xezg

English
3
6
33
4.3K
Alice Ho, MD MBA retweetledi
Gaorav Gupta
Gaorav Gupta@guptalabunc·
Words matter and the title of this @WSJ article (“harsh radiation”) is poorly informed. For a more informative summary of this important 10-year update of the PRIME II trial, I recommend this article: medpagetoday.com/hematologyonco… #bcsm
Harold J. Burstein, MD, PhD, FASCO@DrHBurstein

More breast cancer patients could skip radiation treatment as a study showed deaths were nearly equal whether women received radiation in addition to surgery and hormone therapy wsj.com/articles/breas… via @WSJ

English
2
3
23
5.8K
Alice Ho, MD MBA retweetledi
Shannon M MacDonald
Shannon M MacDonald@ShannonMacDonMD·
My #first tweet- to bring attention to the outdated 18th century laws prohibiting us from providing healthcare to patients across state lines. Covid proved telemedicine was possible. Let’s not go backwards to laws created before the 🚘 & ☎️. ⬇️ @NEJM nejm.org/doi/full/10.10…
English
33
159
726
0
Alice Ho, MD MBA
Alice Ho, MD MBA@AliceHoMD·
@IanJPereira @CarmeloT2681 @Rad_Nation Totally agree. But we need to shift our mindset as Rad Once, to think more biologically and that requires being in touch with all of the progress in systemic therapy, and thinking about how RT can enhance these therapies. #RadOnc #JC
English
2
0
6
0
Radiation Nation
Radiation Nation@Rad_Nation·
What is the vision for the future of #immunoRT and what questions should be asked by clinical trials to accomplish this vision? #radonc #jc
English
1
2
4
0
Carmelo Tuscano🇮🇹🇪🇺
Carmelo Tuscano🇮🇹🇪🇺@CTuscanoMD·
@Rad_Nation I strongly believe in 3 points: 1- Specific trial design with Radiation Oncology perspective 2-Biomarkers based approach 3- Development, inside a Radiation Oncology Dept, of a more biologically focused and translational mentality. New brand : Radiation-Bio-Oncology #radonc #jc.
English
1
8
24
0
Radiation Nation
Radiation Nation@Rad_Nation·
T3: What were the results of this paper? In which global populations may it apply? Are there any considerations from a health equity, diversity, and inclusion lens? #radonc #jc
English
2
0
2
0
Alice Ho, MD MBA
Alice Ho, MD MBA@AliceHoMD·
@Rad_Nation Pembro/RT in metastatic TNBC: those patients with PDL1+disease and receipt of pembro/RT earlier in dz (1L/2L) appeared to benefit. In several months, we will be launching a anti-PD-1/PARP inhibitor/RT in metastatic TNBC who have progressed through IO or are PDL1-. #RadOnc #JC
English
0
2
6
0
Alice Ho, MD MBA
Alice Ho, MD MBA@AliceHoMD·
@HinaSaeedMD @guptalabunc @Rad_Nation One of the strengths of the P-RAD trial is that it has a control arm of IO/NAC (vs. IO+RT/NAC). The inclusion of NAC in all arms is a confounder (as one can argue that pCR in nodes is due to NAC/IO), however if there is an effect from RT, we will see that. #radonc #JC
English
1
0
7
0
Alice Ho, MD MBA
Alice Ho, MD MBA@AliceHoMD·
@Rad_Nation Hi Everyone! My name is Alice Ho. Breast Rad Onc at MGH. Gaorav Gupta and I, along with a number of my co-authors, are available for the next few hours to discuss immunotherapy and RT for breast cancer as part of the Rad Onc Journal Club #radonc #JC .
English
1
0
6
0
Alice Ho, MD MBA
Alice Ho, MD MBA@AliceHoMD·
@HinaSaeedMD Financial toxicities and patient reported outcomes (carefully selected by experienced patient advocates) will be studied on P-RAD #radonc #JC
English
0
0
2
0
Hina Saeed, MD
Hina Saeed, MD@HinaSaeedMD·
#radonc #jc
barttels@barttels2

@IanJPereira @guptalabunc @HinaSaeedMD @AliceHoMD @CGrassberger @oncology_bg @marklewismd @fumikochino @KekoaMDPhD @ChaurasiaMD @Poudyalbishesh @JKleinMD @ashishkjha @j_luh @JordanJ65544091 @Belong_Life @ePatientDave @jonasasouza @DrewMoghanaki @cd_fuller @drcbsteer @FDAOncology @HealthCanada @CADTH_ACMTS It perplexes everyone. Making it even more confusing is that benefits are far from assured before financial toxicity is even considered. Tell me how that works.

QHT
1
0
2
0
Radiation Nation
Radiation Nation@Rad_Nation·
@HenningWillers important point! Is abscopal effect common enough to be clinically meaningful? What is the current status of predictive biomarkers in this domain? @CGrassberger @guptalabunc @BreastDocUK @DavidSherMD @rweichselbaum @CarmeloT2681 @Sushilberiwal #radonc #jc
Henning Willers, MD, FASTRO@HenningWillers

Well, that is not really the question, is it? I have seen it but, really, is it common enough to be clinically meaningful and can we find predictive biomarkers for it? #radonc #jc

English
2
0
4
0
Alice Ho, MD MBA
Alice Ho, MD MBA@AliceHoMD·
@lgotl1230 I'd be interested in this chat, as I've directly seen the benefits (and side effects) of immune therapy in breast ca patients
English
0
1
1
0

Keşfet

@guptalabunc @naimurashid @uncbiostat @UNCpublichealth @UNC_Lineberger @cwspeers @UMichRadOnc @DrSpratticus